Actively Recruiting
Shame-Focused Cognitive Behavioral Therapy For Reducing Suicide Risk In Adolescent Psychiatric Inpatients (SF-CBT)
Led by Peking University · Updated on 2025-12-19
42
Participants Needed
1
Research Sites
59 weeks
Total Duration
On this page
Sponsors
P
Peking University
Lead Sponsor
P
Peking University Sixth Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This pilot randomized controlled trial (RCT) aims to evaluate the feasibility, acceptability, and preliminary efficacy of Shame-Focused Cognitive Behavioral Therapy (SF-CBT) among high-risk psychiatric inpatient adolescents. Shame has been identified as a critical psychological mechanism underlying suicidal ideation and behavior, yet few interventions directly target it. SF-CBT is a structured, manualized intervention designed to reduce shame, improve coping strategies, and lower suicide risk. Approximately 42 adolescents aged 13-18 years, admitted for recent suicide attempt or severe suicidal ideation, will be randomized in a 2:1 ratio to receive either SF-CBT or supportive therapy (ST). Both conditions include 7 individual sessions for adolescents and 3 structured psychoeducation sessions for parents/guardians. Primary outcomes include feasibility metrics (recruitment, retention, adherence, fidelity, adverse events) and acceptability ratings from adolescents, parents, and therapists. Secondary outcomes include changes in suicidal ideation, suicidal behavior, shame, and coping styles, assessed at baseline, post-treatment, and 1-, 3-, and 6-month follow-ups. Findings will inform refinement of the intervention manual, establish feasibility benchmarks, and provide effect size estimates to guide a subsequent large-scale RCT.
CONDITIONS
Official Title
Shame-Focused Cognitive Behavioral Therapy For Reducing Suicide Risk In Adolescent Psychiatric Inpatients (SF-CBT)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adolescents aged 13-18 years, male or female
- Recent suicide risk defined as at least one suicide attempt in the past month, or current suicidal ideation within the past month with or without plan/intent plus at least one previous attempt
- Elevated shame level with a baseline score of 9 or higher on the External and Internal Shame Scale (EISS)
- Adequate cognitive ability to participate in interviews and assessments
- Parent or legal guardian provides informed consent and agrees to participate
You will not qualify if you...
- Current manic episode
- History of schizophrenia spectrum disorder, intellectual disability, or organic brain disease
- Severe psychiatric or medical conditions impairing consent or participation
- Expected to receive electroconvulsive therapy (ECT) during hospitalization
- Anticipated inpatient stay shorter than 14 days to complete the intervention
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University Sixth Hospital
Beijing, Beijing Municipality, China, 100871
Actively Recruiting
Research Team
W
Wanyan Hu, PhD Candidate
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here